Pediatric Hunter syndrome patients
Showing 1 - 25 of >10,000
Hunter Syndrome Trial in India (Elaprase)
Recruiting
- Hunter Syndrome
- Elaprase
-
Thiruvananthapuram, Kerala, India
- +4 more
May 5, 2022
Mucopolysaccharidosis Type II (MPS II) Trial in Brazil, United States (RGX-121)
Recruiting
- Mucopolysaccharidosis Type II (MPS II)
- RGX-121
-
Oakland, California
- +4 more
Dec 22, 2022
Mucopolysaccharidosis Type II Observational
Withdrawn
- Mucopolysaccharidosis II
- Observational
-
Oakland, California
- +2 more
Oct 6, 2022
Identify Pediatric Hunter Syndrome Who Demonstrate Evidence of
Completed
- Hunter Syndrome
- Neurobehavioral testing
- Visual and auditory assessments
-
Chapel Hill, North Carolina
- +1 more
May 18, 2021
Mucopolysaccharidosis Type II Natural History
Completed
- Mucopolysaccharidosis II
-
Pittsburgh, Pennsylvania
- +2 more
Apr 22, 2022
Hunter Syndrome Trial in Worldwide (Idursulfase-IT, Elaprase)
Active, not recruiting
- Hunter Syndrome
-
Oakland, California
- +8 more
Aug 31, 2022
Hunter Syndrome Trial in Chapel Hill, Birmingham (Control, Idursulfase IT (1 mg), Idursulfase IT (10 mg))
Completed
- Hunter Syndrome
- Control
- +3 more
-
Chapel Hill, North Carolina
- +2 more
Jun 24, 2021
Neurodevelopmental Status in Pediatric Hunter Syndrome (MPS II)
Completed
- Mucopolysaccharidosis (MPS)
- Hunter Syndrome
-
Oakland, California
- +6 more
Mar 15, 2021
Hunter Syndrome Trial in Lexington
Recruiting
- Hunter Syndrome
-
Lexington, MassachusettsShire
Nov 7, 2022
Hunter Syndrome Trial in Canada, United Kingdom, United States (Idursulfase-IT, Elaprase)
Active, not recruiting
- Hunter Syndrome
-
Chicago, Illinois
- +8 more
Mar 11, 2021
Hunter Syndrome Trial in Canada, France (Idursulfase-IT, Elaprase)
Not yet recruiting
- Hunter Syndrome
-
Calgary, Alberta, Canada
- +3 more
Sep 4, 2023
Rett Syndrome Trial (TSHA-102)
Not yet recruiting
- Rett Syndrome
- TSHA-102
- (no location specified)
Nov 21, 2023
Mucopolysaccharidosis (MPS), Hunter Syndrome Trial (ELAPRASE, Rituximab, Methotrexate)
Not yet recruiting
- Mucopolysaccharidosis (MPS)
- Hunter Syndrome
- ELAPRASE
- +3 more
- (no location specified)
Aug 8, 2022
Mucopolysaccharidosis II Trial in Oakland (JR-141)
Not yet recruiting
- Mucopolysaccharidosis II
-
Oakland, CaliforniaUCSF Benioff Children's Hospital Oakland
Oct 21, 2022
Nephrotic Syndrome in Children, Telitacicept Trial in Hangzhou (Telitacicept)
Recruiting
- Nephrotic Syndrome in Children
- Telitacicept
-
Hangzhou, Zhejiang, ChinaChildren's Hospital, Zhejiang University School of Medicine
Nov 8, 2023
Nephrotic Syndrome Trial in Tanta (renal doppler)
Recruiting
- Nephrotic Syndrome
- renal doppler
-
Tanta, EgyptSara Mabrouk Mohamed Elghoul
Jun 11, 2023
Mucopolysaccharidosis Type II (MPS II) Trial in Oakland, Montréal (RGX-121)
Recruiting
- Mucopolysaccharidosis Type II (MPS II)
- RGX-121
-
Oakland, California
- +1 more
Oct 6, 2022
Irritable Bowel Syndrome Trial in Roma (palmithoylethanolamide/polydatin, )
Recruiting
- Irritable Bowel Syndrome
- palmithoylethanolamide/polydatin
- placebo
-
Roma, Rome, ItalyProf Giovanni Di Nardo
May 10, 2023
Orthostatic Intolerance in the Context of Pediatric ME/CFS
Completed
- Chronic Fatigue Syndrome in Adolescence
- +2 more
-
Munich, Bavaria, GermanyMRI Chronic Fatigue Center for Young People (MCFC) Children's Ho
Sep 22, 2023
Irritable Bowel Syndrome With Constipation (IBS-C) Trial in Foley (Tenapanor)
Enrolling by invitation
- Irritable Bowel Syndrome With Constipation (IBS-C)
-
Foley, AlabamaG & L Research, LLC
Jun 13, 2023
Pediatric Inflammatory Heart Diseases
Not yet recruiting
- Myocarditis
- +2 more
- study of biological samples and echocardiographic data and link with need of hemodynamic support
-
Vandœuvre-lès-Nancy, FranceGilles BOSSER
Jun 20, 2023
Marfan Syndrome and Quality of Life of Pediatric Patients
Recruiting
- Rare Diseases
- Pediatric Disorder
- Questionnaire
-
San Donato Milanese, Lombardia, ItalyIRCCS Policlinico San Donato
Feb 24, 2023